Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.

Verghese PS, Schmeling DO, Knight JA, Matas AJ, Balfour HH Jr.

Transplantation. 2015 Mar;99(3):602-8. doi: 10.1097/TP.0000000000000354.

2.

Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation.

Verghese PS, Schmeling DO, Knight JA, Matas AJ, Balfour HH Jr.

Transplantation. 2015 Jun;99(6):1186-91. doi: 10.1097/TP.0000000000000490.

PMID:
25489844
3.

Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.

Opelz G, Daniel V, Naujokat C, Döhler B.

Transplantation. 2009 Oct 27;88(8):962-7. doi: 10.1097/TP.0b013e3181b9692d.

PMID:
19855238
4.

Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.

Schwarz A, Linnenweber-Held S, Heim A, Framke T, Haller H, Schmitt C.

Transplantation. 2016 Apr;100(4):844-53. doi: 10.1097/TP.0000000000001066.

PMID:
26720302
5.

CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.

Elfadawy N, Flechner SM, Liu X, Schold J, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB.

Transplantation. 2013 Dec 27;96(12):1097-103. doi: 10.1097/TP.0b013e3182a6890d.

PMID:
24056621
6.

Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.

Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, Howard A, Wojciechowski D.

Transplantation. 2017 Jun;101(6):1495-1505. doi: 10.1097/TP.0000000000001261.

PMID:
27854236
7.

Prevalence of BK virus replication among recipients of solid organ transplants.

Muñoz P, Fogeda M, Bouza E, Verde E, Palomo J, Bañares R; BKV Study Group.

Clin Infect Dis. 2005 Dec 15;41(12):1720-5. Epub 2005 Nov 10.

PMID:
16288394
8.

Donor origin of BKV replication after kidney transplantation.

Schmitt C, Raggub L, Linnenweber-Held S, Adams O, Schwarz A, Heim A.

J Clin Virol. 2014 Feb;59(2):120-5. doi: 10.1016/j.jcv.2013.11.009. Epub 2013 Dec 1.

PMID:
24361208
9.

Prevalence of BK polyomavirus infection and association with renal dysfunction in pediatric heart transplant recipients.

Ducharme-Smith A, Katz BZ, Bobrowski AE, Backer CL, Rychlik K, Pahl E.

J Heart Lung Transplant. 2015 Feb;34(2):222-6. doi: 10.1016/j.healun.2014.09.043. Epub 2014 Oct 24.

PMID:
25540880
10.

Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients.

Barzon L, Murer L, Pacenti M, Biasolo MA, Vella MD, Ghirardo G, Gamba PG, De Arias AE, Zanon GF, Palù G.

J Infect Dis. 2009 Nov 1;200(9):1425-33. doi: 10.1086/644504.

PMID:
19803803
11.

Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?

Saghafi H, Qorashi M, Heidari A.

Transplant Proc. 2009 Sep;41(7):2761-3. doi: 10.1016/j.transproceed.2009.07.057.

PMID:
19765428
12.

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.

Toyoda M, Shin BH, Ge S, Mirocha J, Thomas D, Chu M, Rodriguez E, Chao C, Petrosyan A, Galera OA, Vo A, Choi J, Peng A, Kahwaji J, Jordan SC.

J Immunol Res. 2017;2017:5672523. doi: 10.1155/2017/5672523. Epub 2017 Feb 6.

13.

Pretransplant serologic testing to identify the risk of polyoma BK viremia in pediatric kidney transplant recipients.

Ali AM, Gibson IW, Birk P, Blydt-Hansen TD.

Pediatr Transplant. 2011 Dec;15(8):827-34. doi: 10.1111/j.1399-3046.2011.01583.x.

PMID:
22111998
14.

Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.

Puliyanda DP, Amet N, Dhawan A, Hilo L, Radha RK, Bunnapradist S, Czer L, Martin P, Jordan S, Toyoda M.

Clin Transplant. 2006 May-Jun;20(3):289-94.

PMID:
16824143
15.

Meaning of early polyomavirus-BK replication post kidney transplant.

Mitterhofer AP, Pietropaolo V, Barile M, Tinti F, Fioriti D, Mischitelli M, Limonta A, Meçule A, Ferretti G, Poli L, Chiarini F, Berloco PB, Taliani G.

Transplant Proc. 2010 May;42(4):1142-5. doi: 10.1016/j.transproceed.2010.03.130.

PMID:
20534245
16.

Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.

Schönberger S, Meisel R, Adams O, Pufal Y, Laws HJ, Enczmann J, Dilloo D.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1428-35. doi: 10.1016/j.bbmt.2010.04.008. Epub 2010 Apr 24.

17.

Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.

Aldridge RW, Mattes FM, Rolando N, Rolles K, Smith C, Shirling G, Atkinson C, Burroughs AK, Milne RS, Emery VC, Griffiths PD.

Transpl Infect Dis. 2015 Feb;17(1):25-32. doi: 10.1111/tid.12325. Epub 2015 Jan 9.

18.

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia.

Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Schnitzler MA, Major EO, Brennan DC.

Am J Transplant. 2005 Sep;5(9):2213-21.

19.

BK virus infection and its effect on renal function in pediatric liver-transplant recipients: a cross-sectional, longitudinal, prospective study.

Amir A, Shapiro R, Shulman LM, Mor E, Steinberg R, Fleishhacker H, Bergerin R, Avitzur Y.

Transplantation. 2011 Oct 27;92(8):943-6. doi: 10.1097/TP.0b013e31822e0b9a.

PMID:
21876478
20.

Prospective monitoring of BK virus replication in renal transplant recipients.

Koukoulaki M, Grispou E, Pistolas D, Balaska K, Apostolou T, Anagnostopoulou M, Tseleni-Kotsovili A, Hadjiconstantinou V, Paniara O, Saroglou G, Legakis N, Drakopoulos S.

Transpl Infect Dis. 2009 Feb;11(1):1-10. doi: 10.1111/j.1399-3062.2008.00342.x. Epub 2008 Sep 21.

PMID:
18811631

Supplemental Content

Support Center